Lexeo Therapeutics, Inc. reports acquisition or asset disposition

Lexeo Therapeutics, Inc. filed an 8-K covering an acquisition or disposition of assets and an unregistered sale of equity securities. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.